The Potential of Givinostat as DDI Victim in Co-administration P-gp Inhibitor (Part 2)

Clinical trial NCT05845567 · COMPLETED

Trial details

NCT number: NCT05845567
Sponsor: Italfarmaco
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug Drug Interaction

Start date: 2022-03-21
Primary completion: 2022-05-08
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.